Pediatric Stem Cell Research Institute, Edmond and Lily Sara Children's Hospital, Sheba Medical Center, Tel Hashomer, Ramat-Gan, Israel; Pediatric Research Center for Genetics, Development and Environment, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
The Maurice and Gabriela Goldschleger Eye Research Institute, Sheba Medical Center, Ramat-Gan, Israel.
Cell Rep. 2020 Jan 21;30(3):852-869.e4. doi: 10.1016/j.celrep.2019.12.047.
End-stage renal disease is a worldwide epidemic requiring renal replacement therapy. Harvesting tissue from failing kidneys and autotransplantation of tissue progenitors could theoretically delay the need for dialysis. Here we use healthy and end-stage human adult kidneys to robustly expand proliferative kidney epithelial cells and establish 3D kidney epithelial cultures termed "nephrospheres." Formation of nephrospheres reestablishes renal identity and function in primary cultures. Transplantation into NOD/SCID mice shows that nephrospheres restore self-organogenetic properties lost in monolayer cultures, allowing long-term engraftment as tubular structures, potentially adding nephron segments and demonstrating self-organization as critical to survival. Furthermore, long-term tubular engraftment of nephrospheres is functionally beneficial in murine models of chronic kidney disease. Remarkably, nephrospheres inhibit pro-fibrotic collagen production in cultured fibroblasts via paracrine modulation, while transplanted nephrospheres induce transcriptional signatures of proliferation and release from quiescence, suggesting re-activation of endogenous repair. These data support the use of human nephrospheres for renal cell therapy.
终末期肾病是一种全球性的流行疾病,需要肾脏替代治疗。从衰竭的肾脏中采集组织并进行组织祖细胞的自体移植,从理论上讲可以延缓透析的需要。在这里,我们使用健康和终末期的成人人类肾脏,以强有力地扩增增殖性肾脏上皮细胞,并建立称为“肾小体”的 3D 肾脏上皮培养物。肾小体的形成在原代培养物中重新建立了肾脏的身份和功能。移植到 NOD/SCID 小鼠中表明,肾小体恢复了在单层培养中丢失的自我发生特性,允许作为管状结构长期植入,可能增加肾单位片段并证明自我组织对于生存至关重要。此外,肾小体在慢性肾脏病的小鼠模型中具有长期的管状植入功能益处。值得注意的是,肾小体通过旁分泌调节抑制培养的成纤维细胞中促纤维化胶原的产生,而移植的肾小体诱导增殖和从静止中释放的转录特征,表明内源性修复的重新激活。这些数据支持使用人类肾小体进行肾脏细胞治疗。